| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |